Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)
Status:
Withdrawn
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerance, pharmacokinetics, and
pharmacodynamics of sobetirome, a selective thyroid hormone analog, in adult male X-ALD
patients.